GlassScriptPhysician profile
Rita P Kaplon
NPI 1538547385
$14,178.82
in general payments reported to CMS, 2019-2025
22 companies · $1,795 in 2025
The $1,795 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.93 · 2020: $77.12 · 2021: $32.57 · 2022: $325 · 2023: $284 · 2024: $12K · 2025: $1,795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,000 · Travel and Lodging: $3,595 · Food and Beverage: $1,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,000.00 |
| Travel and Lodging | $3,594.86 |
| Food and Beverage | $1,085.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,901.67 | 2024-2025 | |
| Astellas Pharma US INC | $273.68 | 2022-2025 | Veozah |
| Abbvie INC. | $245.78 | 2019-2023 | |
| Biogen, INC. | $134.36 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $100.37 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $95.20 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $54.79 | 2023-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $52.30 | 2022-2024 | |
| Astellas Pharma Global Development | $48.17 | 2024-2025 | Veozah |
| Minerva Surgical, INC | $42.35 | 2020 | |
| Exeltis, USA INC. | $37.83 | 2024-2025 | Slynd |
| Myovant Sciences INC. | $26.07 | 2022 | |
| Organon LLC | $25.06 | 2022-2024 | |
| Avion Pharmaceuticals | $22.75 | 2022 | |
| Roche Diagnostics Corporation | $22.45 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $19.71 | 2024 | Paragard T 380a |
| Ascend Therapeutics US, LLC | $17.02 | 2023 | |
| Exact Sciences Corporation | $15.04 | 2025 | The Cologuard Plus Collection Kit |
| Aspira Women'S Health INC | $14.38 | 2024 | Ova1 |
| Channel Medsystems, INC. | $11.23 | 2025 | |
| Daiichi Sankyo INC. | $10.92 | 2019 | |
| Mayne Pharma Commercial LLC | $7.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Kaplon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.